Company / Interest Expense per Share
Merck & Co. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.45
FY2023
5-year range
$0.31 / $0.45
FY2019-FY2023
Trend
+19.3%
vs FY2022
Sector context
#13 of 43
Health Care
What the data says
At $0.45, Merck & Co.'s interest expense per share ranks #31 of 43 in the Health Care sector. Interest Expense per Share has increased for 3 consecutive years, from $0.31 in FY2020 to $0.45 in FY2023.
Based on SEC 10-K filings.
0.45 in FY2023 with a 5-year CAGR of +10.3%.
Increased from $0.31 to $0.45 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +13.3%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
#31 of 43 in Health CareTop 70% of 43This company $0.45 Sector average $18.61
▼
-97.6% below sector average
Key checks
Key Insights
- Merck & Co.'s interest expense per share has grown for 3 consecutive years.
- In FY2023, interest expense per share increased 19.3% year-over-year.
- Ranks #13 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.45 | +19.3% |
| FY2022 | $0.38 | +21.2% |
| FY2021 | $0.31 | +0.7% |
| FY2020 | $0.31 | -4.5% |
| FY2019 | $0.32 | +17.3% |
| FY2018 | $0.28 | +4.4% |
| FY2017 | $0.27 | +12.1% |
| FY2016 | $0.24 | +5.5% |
As of FY2023 · SEC 10-K · Updated Mar 9, 2026